Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.14M 1.97M 1.84M 3.46M 230M 3.53M 23.66M 9.16M 114M 9.15M 8.95M 394M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.92M 10.07M 9.43M 17.68M 1.18B 18.04M 121M 46.83M 581M 46.78M 45.76M 2.01B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-2.30%-2.86%-30.47%+13.71% 15.33B
-1.05%+14.81%+28.16%+41.52% 7.64B
+1.61%-5.36%-49.43%-61.59% 7.31B
-1.55%-1.30%-26.05%+230.01% 3.95B
-4.23%-3.71%-37.63%-47.84% 2.03B
-2.65%-5.97%-38.93%-51.25% 1.71B
+2.01%+2.19%-10.04%+27.61% 1.53B
-1.14%+0.42%+2.20%+74.71% 1.48B
+2.86%+1.11%-8.23%+72.42% 1.18B
Average -0.64%-1.45%-18.94%+33.26% 4.22B
Weighted average by Cap. -1.09%-1.45%-20.89%+24.66%

Financials

2018 2019 *
Net sales 3.32M 2.91M 2.68M 2.51M 4.71M 313M 4.81M 32.27M 12.49M 155M 12.47M 12.2M 537M -
Net income -15.94M -13.98M -12.88M -12.06M -22.61M -1.5B -23.08M -155M -59.91M -743M -59.85M -58.54M -2.58B -
Net Debt 10.02M 8.79M 8.1M 7.58M 14.22M 945M 14.52M 97.36M 37.67M 467M 37.63M 36.81M 1.62B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock